White Paper / Infographic

The Changing Face of Global Clinical Trials: Asia-Pacific as an Ideal Destination for Specialty Biopharma

September 2017, A Frost & Sullivan White Paper

Introduction

The contract research organization (CRO) market in the Asia-Pacific (APAC) region is the fastest- growing in the world, with revenue expected to increase at a 20% compound annual growth rate (CAGR) from 2016 to 2021 compared with the rest of the world’s 11.4% CAGR.

Table of Contents

  • EXECUTIVE SUMMARY
  • TRANSFORMATION UNDERWAY IN THE BIOPHARMA INDUSTRY
  • SHIFT TO OUTSOURCING AND CROs
  • APAC ON THE RISE
  • WORKING WITH THE RIGHT DEVELOPMENT PARTNER: CMIC
  • THE LAST WORD

 

Infographic

The Changing Face of Global Clinical Trials: Asia-Pacific as an Ideal Destination for Specialty Biopharma

 
info-1.png

Inquiries about our services

Click here if you are interested in outsourcing your operations to us.

SHARE